Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers
Chengheng Liao(Southwestern Medical Center), Qing Zhang(Southwestern Medical Center), Akash Kaushik(Baylor College of Medicine), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Kevin R. Mott(University of North Carolina at Chapel Hill), Hieu Vu(The University of Texas Southwestern Medical Center), Jason W. Locasale(Duke University), Charles M. Perou(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), Cherise Ryan Glodowski(University of North Carolina at Chapel Hill), Juan Liu(Shandong University of Traditional Chinese Medicine), Ralph J. DeBerardinis(Children's Medical Center)
Cited by 34
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k